Search Results - "ROSE, P. G"

Refine Results
  1. 1

    Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study by Rose, P G, Blessing, J A, Mayer, A R, Homesley, H D

    Published in Journal of clinical oncology (01-02-1998)
    “…A phase II trial was conducted to determine the activity of prolonged oral etoposide in platinum-resistant and platinum-sensitive ovarian carcinoma…”
    Get more information
    Journal Article
  2. 2

    Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer by Rose, Peter G, Bundy, Brian N, Watkins, Edwin B, Thigpen, J. Tate, Deppe, Gunther, Maiman, Mitchell A, Clarke-Pearson, Daniel L, Insalaco, Sam

    Published in The New England journal of medicine (15-04-1999)
    “…Cervical cancer is the second most frequent cancer among women worldwide and the most frequent cancer among women in Africa, Asia, and South America. 1 In the…”
    Get full text
    Journal Article
  3. 3

    Chemoradiotherapy for cervical cancer by Rose, P.G

    Published in European journal of cancer (1990) (2002)
    “…Cervical cancer remains a major health problem worldwide, despite advances in screening. For patients with locally advanced stage disease, failure to obtain…”
    Get full text
    Journal Article
  4. 4

    Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer by GORDON, A. N, GRANAI, C. O, ROSE, P. G, HAINSWORTH, J, LOPEZ, A, WEISSMAN, C, ROSALES, R, SHARPINGTON, T

    Published in Journal of clinical oncology (17-09-2000)
    “…Stealth liposomal doxorubicin (Alzal Corp, Palo Alto, CA) has a slower clearance rate than free doxorubicin, resulting in sustained serum levels. Liposomal…”
    Get full text
    Journal Article
  5. 5

    Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic Study by ROSE, P. G, ADLER, L. P, RODRIGUEZ, M, FAULHABER, P. F, ABDUL-KARIM, F. W, MIRALDI, F

    Published in Journal of clinical oncology (01-01-1999)
    “…Positron emission tomographic (PET) scanning provides a novel means of imaging malignancies. This prospective study was undertaken to evaluate PET scanning in…”
    Get full text
    Journal Article
  6. 6

    Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma by Rose, P G, Fusco, N, Fluellen, L, Rodriguez, M

    Published in Journal of clinical oncology (01-04-1998)
    “…The combination of paclitaxel and a platinum compound is the most active first-line regimen for advanced ovarian carcinoma. The current study was undertaken to…”
    Get more information
    Journal Article
  7. 7

    Paclitaxel and Cisplatin as First-Line Therapy in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study by ROSE, P. G, BLESSING, J. A, GERSHENSON, D. M, MCGEHEE, R

    Published in Journal of clinical oncology (01-09-1999)
    “…On the basis of the activity of paclitaxel as a single agent in chemotherapy-naive squamous cell carcinoma of the cervix in a prior Gynecologic Oncology Group…”
    Get full text
    Journal Article
  8. 8

    Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study by Varia, M A, Bundy, B N, Deppe, G, Mannel, R, Averette, H E, Rose, P G, Connelly, P

    “…A multicenter trial of chemoradiation therapy to evaluate the feasibility of extended field radiation therapy (ERT) with 5-fluorouracil (5-FU) and cisplatin,…”
    Get more information
    Journal Article
  9. 9

    Surgery for recurrent ovarian cancer by Rose, P G

    Published in Seminars in oncology (01-06-2000)
    “…Recurrent ovarian cancer is associated with a poor long-term prognosis and optimal management for this problem is not well defined. The benefits of primary…”
    Get more information
    Journal Article
  10. 10

    Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma by Rose, P G

    “…Platinum compounds are the key components of chemotherapy for ovarian cancer. Preclinical models in an ovarian cancer cell line (A2780) have demonstrated…”
    Get more information
    Journal Article
  11. 11

    Synthesis and characterization of methylcellulose from sugar cane bagasse cellulose by Viera, Rose G.P., Filho, Guimes Rodrigues, de Assunção, Rosana M.N., S. Meireles, Carla da, Vieira, Júlia G., de Oliveira, Grasielle S.

    Published in Carbohydrate polymers (22-01-2007)
    “…In the present paper, methylcellulose was produced from cellulose extracted of sugar cane bagasse, using dimethyl sulfate in heterogeneous conditions. The…”
    Get full text
    Journal Article
  12. 12

    Paclitaxel, an Active Agent in Nonsquamous Carcinomas of the Uterine Cervix: A Gynecologic Oncology Group Study by CURTIN, Y. John P, BLESSING, John A, WEBSTER, Kenneth D, ROSE, Peter G, MAYER, Allan R, FOWLER, Wesley C, MALFETANO, John H, ALVAREZ, Ronald D

    Published in Journal of clinical oncology (01-03-2001)
    “…A phase II trial of paclitaxel was initiated in advanced nonsquamous carcinoma of the cervix to determine its activity in patients who had failed standard…”
    Get full text
    Journal Article
  13. 13

    Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study by FRACASSO, Paula M, BRADY, Mark F, MOORE, David H, WALKER, Joan L, ROSE, Peter G, LETVAK, Laurie, GROGAN, Thomas M, MCGUIRE, William P

    Published in Journal of clinical oncology (15-06-2001)
    “…A phase II study was conducted to determine the efficacy of paclitaxel and valspodar (PSC 833) in patients with advanced epithelial ovarian cancer. Valspodar,…”
    Get full text
    Journal Article
  14. 14

    Chemoradiotherapy : The new standard care for invasive cervical cancer by ROSE, Peter G

    Published in Drugs (New York, N.Y.) (01-12-2000)
    “…Cervical cancer remains a major health problem worldwide, despite advances in screening. For patients with locally advanced stage disease, failure to obtain…”
    Get full text
    Journal Article
  15. 15

    Endometrial Carcinoma by Rose, Peter G

    Published in The New England journal of medicine (29-08-1996)
    “…Uterine cancer is the fourth most frequent cancer in women, with an estimated 34,000 cases and 6000 deaths in the United States in 1996. 1 It is the most…”
    Get full text
    Journal Article
  16. 16

    Malignant melanoma of the vulva: An extension of cutaneous melanoma? by Moxley, K.M, Fader, A.N, Rose, P.G, Case, A.S, Mutch, D.G, Berry, E, Schink, J.C, Kim, C.H, Chi, D.S, Moore, K.N

    Published in Gynecologic oncology (01-09-2011)
    “…Abstract Objective To determine the prognostic significance of the 2002 revisions of the American Joint Committee on Cancer (AJCC) Staging System for cutaneous…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Amifostine cytoprotection with chemotherapy for advanced ovarian carcinoma by Rose, P G

    Published in Seminars in oncology (01-08-1996)
    “…To determine the efficacy of pretreatment with amifostine in diminishing the hematologic and nonhematologic toxicities of cyclophosphamide and cisplatin in…”
    Get more information
    Journal Article
  19. 19

    Midpoint transverse process to pleura catheter placement for postoperative analgesia following video‐assisted thoracoscopic surgery by Watton, D. E., Rose, P. G. D., Abdallah, F. W., Thompson, C. P., Maziak, D. E., Costache, I.

    Published in Anaesthesia reports (01-07-2019)
    “…Summary The ultrasound‐guided midpoint transverse process to pleura block has been described as an alternative end‐point for thoracic paravertebral blockade…”
    Get full text
    Journal Article
  20. 20

    Malignant Struma Ovarii: Recurrence and Response to Treatment Monitored by Thyroglobulin Levels by Rose, Peter G., Arafah, Baha, Abdul-Karim, Fadi W.

    Published in Gynecologic oncology (01-09-1998)
    “…A patient with malignant struma ovarii who had elevated thyroglobulin levels at the time of her original surgery was diagnosed with recurrence on the basis of…”
    Get full text
    Journal Article